SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001829126-23-004464
Filing Date
2023-06-29
Accepted
2023-06-29 09:00:21
Documents
13
Period of Report
2023-06-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K organicellrege_8k.htm   iXBRL 8-K 40636
2 EXHIBIT 99.1 organicell_ex99-1.htm EX-99.1 12634
  Complete submission text file 0001829126-23-004464.txt   225612

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ocel-20230629.xsd EX-101.SCH 3021
4 XBRL LABEL FILE ocel-20230629_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE ocel-20230629_pre.xml EX-101.PRE 22363
7 EXTRACTED XBRL INSTANCE DOCUMENT organicellrege_8k_htm.xml XML 3044
Mailing Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314
Business Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314 888-963-7881
Organicell Regenerative Medicine, Inc. (Filer) CIK: 0001557376 (see all company filings)

IRS No.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 000-55008 | Film No.: 231054585
SIC: 2836 Biological Products, (No Diagnostic Substances)